Lion's Dental Supply & Equipment

Quality Dental Operatory Equipment, Autoclaves & Supplies...All at the Lowest Prices !!                      
White Back Ground
Face Masks
Surgical Disposable Face Masks
SureSeal ASTM Level 3 Fog Free Double Chin Masks
SureSeal ASTM Level 3 Black Surgical Face Masks
SureSeal ASTM Level 2 Surgical Face Masks
SureSeal ASTM Level 1 Surgical Face Masks
Extra Safe Fog Free ASTM Level 3 Surgical Masks
Omega ASTM Level 2 Light Blue Surgical Face Masks
Halyard 47577 ASTM Level 1 Procedure Mask
Cranberry Carbon 4 Ply Black ASTM Level 3 Masks
Crosstex IsoFluid Resistant Earloop Face Mask
Defend Level 3 Earloop Face Masks
Earloop Triple Layer Filtration Face Masks
N95 Medical Particulate Respirator Face Masks
Colored KN95 Particulate Respirator Masks
3M 9502V+ KN95 Medical Particulate Respirator Mask
3M 9542V+ KN95 Medical Particulate Respirator Mask
3M 9502+ KN95 Medical Particulate Respirator Mask
3M 9501+ KN95 Medical Particulate Respirator Mask
3M 9010 N95 Particulate Respirator CDC Approved
3M 9210+ N95 Particulate Respirator CDC Approved
ProGear N95 Surgical Particulate Respirator
Honeywell DC365N95HC Surgical N95 Respirators
3M 8210V N95 Niosh Approved Particulate Respirator
3M 8210 N95 Niosh Approved Particulate Respirator
3M 8511 N95 Niosh Approved Particulate Respirator
3M 1860 N95 Niosh Approved Particulate Respirators
3M 1870+N95 Niosh Approved Particulate Respirators
Marcio KN95 Medical Particulate Respirator Mask
MakRite Medical N95 Particulate Respirator Masks
Moldex 2200N95 Series Particulate Respirator
Moldex 2300N95 Series Respirator Masks
HDX H950 N95 Particulate Respirator Masks
SAS 8610 Medical N95 Particulate Respirator Masks
UniAir N95 Medical Particulate Respirator Mask
Medical Full Face Shields for Covid-19 Protection
Air Abrasion System- Dental
Air Compressors-Dental
Air Polishers & Scalers
Apex Locators
Autoclaves & Sterilizers
Bleaching Dental Light Systems
Chairs Operatory
Curing Light Units- Halogen & Led
Delivery Units & Mobile Carts
Digital X-Ray Sensors
Electrosurgery Units For Dental
Endodontic Rotary Systems
Endodontic Obturation & Thermal Condensors
Film Processors
Implant Motor Systems
Intraoral Cameras
Laboratory Equipment
Laboratory Micro Motors
Mobile Carts
Operatory Lights
Operatory Packages
Phosphor Plate Scanner Digital X-Ray System
Piezo Scalers
Portable Delivery Units
Ultrasonic Cleaners
Ultrasonic Scalers
Vacuum Systems
X-Ray Equipment
X Ray Units
terms and conditions
Leasing And Financing
Shows & Conventions
Career opportunities

3M 9502V+ KN95 Particulate Respirator Masks With Valve

As there is a world wide shortage of Disposable Surgical Medical Face Masks Because of the CoronaVirus. These are Special Order and there are no returns. The sale of this item is subject to regulation by the U.S. FDA and therefore is Non Returnable. Once the Order is Placed we can not Cancel the Order as it goes to the Warehouse that ships the product out as fast as possible to Help those in Need.

We have all these Face Masks in Stock and Ready to ship. 1 to 5 Days Delivery Time.

3M 9502V+ KN95 Medical N95 Particulate Respirator Masks With Valve

3M 9502V+ KN95 Particulate Respirator Masks With Valve

The 3M 9502V+ Particulate Respirators authorized for emergency use by healthcare personal during the COVID-19 public health emergency By FDA & CDC. The 3M 9502V+ Particulate Respirator is a disposable particulate respirator that is designed to help provide reliable respiratory protection of at least 95 percent filtration efficiency against particles. This respirator can also help reduce inhalation exposures to certain biological particles (examples: mold, Bacillus anthracis, Mycobacterium tuberculosis), but cannot eliminate the risk of contracting infection, illness, or disease. Soft inner material provides added comfort while the cup shape design makes the respirator spacious and durable. Adjustable M noseclip helps provide a custom and secure seal. The respirator incorporates 3M proprietary technology with advanced electrostatically charged microfiber filter media designed for ease of breathing. This respirator is compatible with a variety of protective eyewear and hearing protection. These Usually come in a bag of 25.

-Non-woven fabric & Knitted headband
-Adjustable noseclip
-Soft and Breathable
-Vertical folding design, lightweight structure
-Efficient protection
-KN95 are the same as N95 In performance.
-With Valve to keep you cool during summer

-FDA & CDC Authorized the use of 3M 9502V+ KN95 Respirators for emergency use by healthcare personal during the COVID-19 public health emergency.

Reg $ 37.99  Sold Out


SAS 8610 N95 Masks In Stock

3M 9502V+ KN95 Medical N95 Particulate Respirator Masks 19 Pk Sold Out  

3M 9502V+ KN95 Medical N95 Particulate Respirator Masks 25 Pk Sold Out  

3M 9502V+ KN95 Medical N95 Particulate Respirator Masks 50 Pk Sold Out  

3M 9502V+ KN95 Medical N95 Particulate Respirator Masks 100 Pk Sold Out  


3M Respirators in International Packaging Made Available in US during COVID-19
3M is continuing to address the COVID-19 pandemic with many tactics to help protect those responding to the outbreak, including healthcare workers and first responders. In early April, 3M reached agreement with the U.S. government on a plan that, with the Trump Administration’s assistance, will enable FEMA to import 166.5 million respirators into the United States over a 3-month period starting in April, from our plants in Asia.

3M Respirators in International Packaging Made Available in US during COVID-19 (PDF, 96.38 KB)

Respirators from Asia Imported and Distributed by FEMA (PDF, 115.88 KB)

3M Filtering Facepiece Respirators Imported to U.S. from Asia by FEMA (PDF, 546.30 KB)

3M 9502V+ Particulate Respirator, User Instructions (PDF, 316.01 KB)

Non-NIOSH Approved Respirators
Emergency User Authorization (EUA) End User Information
The following 3M respirators are listed in Appendix A of the April 3rd, 2020 EUA title imported, “Non-NIOSH-Approved Disposable
Filtering Facepiece Respirators Manufactured in China”. Users should read the information below for their model before use. Please
note these are also listed at
9552/9552V, 9502, 9542, 9542V
9501, 9501+/9501V+, 9505+, 9541, 9541V
• 9502+/9502V+
• 8822 (AU), 8822 (K)

On April 3, 2020, the FDA issued an umbrella EUA for certain filtering face-piece respirators (FFRs) that are manufactured in China and are not approved by the National Institutes of Occupational Safety and Health (NIOSH). As mentioned in CDC's strategies for optimizing respirator supply, other countries approve respirators according to country-specific standards. These devices are evaluated using methods similar to those used by NIOSH and are still expected to provide adequate protection for healthcare personnel. Non-NIOSH-approved FFRs manufactured in China that have been confirmed by FDA to meet the criteria under the EUA are included below in Appendix A. Additionally, the FDA, in collaboration with CDC NIOSH, is increasing surveillance and sampling of all respirators imported from China - all respirator shipments from China that come into the U.S. will be subject to random sampling and testing by CDC NIOSH to determine whether the respirator meets the expected particulate filtration standards.

5 myths about the COVID-19 vaccine
As COVID-19 vaccines become more available, so do the myths and misinformation that spread about the vaccines. This dentist wants to dispel the myths.

There has been much misinformation shared about the COVID-19 vaccines. As health-care professionals, we should be well informed and should pass on evidence-based facts related to the vaccines. I hope this information provides a resource to help dispel the many myths that we’re hearing.


MYTH: This vaccine was created too quickly, so safety must have been compromised.

FACT: The speed that enabled this vaccine to be in use in less than one year is due to several factors.


Past vaccines required the use of human cells to actually grow the virus used in the vaccine. It takes a long time to harvest human cells, grow the virus in those cells, harvest and purify the virus, kill or render the virus less infectious, and then formulate the carrier for the virus in order to make the final vaccine. Since no part of the virus is used in the messenger RNA (mRNA) vaccine, this time consuming (months long) process was avoided. Instead, the mRNA can be made synthetically, and mass produced quickly.
Since the genetic code of the virus was known in January 2020, manufacturing of the mRNA was able to begin then. This enabled clinical trials to start quickly and both the Pfizer and Moderna trials had 30,000 to 40,000 participants. Due to the continued spread and high infection rates of COVID-19, the clinical trials were finished much more quickly than normal. With trials for previous vaccines there were so few infections that it took much longer to determine if there was a protective effect from the vaccine, which prolonged the clinical trials.
The Food and Drug Administration review was as thorough as for any vaccine but was expedited due to the urgent need.
Finally, actual vaccine production would typically not start until after FDA approval. But because the government ordered and paid for hundreds of millions of doses in advance, pharmaceutical companies began producing them even before clinical testing was started.
MYTH: The mRNA vaccine can change or enter your DNA.

FACT: mRNA cannot alter your DNA. It can only enter your cells, not your DNA. It then instructs your DNA to make the spike protein of the coronavirus that your body recognizes as foreign and develops immunity against. After that the mRNA dissolves.

MYTH: This is new technology so it may not be safe.

FACT: mRNA technology has been around for more than 10 years. It was unable to be used in a vaccine because when it was being developed for zika, SARS, and MERS, those viruses disappeared and clinical trials could not be completed. Ultimately there was no need for vaccines against those viruses.

MYTH: This vaccine could cause infertility in women.

FACT: The placenta has a protein with a short sequence of amino acids (the building blocks of all proteins) in common with the spike protein of coronavirus. It is said that this could lead to antibodies in the spike protein attacking the placenta. Many proteins have common amino acid sequences, and this sequence is so short it is meaningless. Additionally, nearly 45,000 pregnant women have been infected with COVID-19, causing antibody development to the spike protein, and they have had no greater miscarriage rates than women not infected with COVID-19. However, the COVID-19 infection has led to pregnancy complications in some women, including higher risk of preterm delivery, preeclampsia, ICU admission, and death. Over 10,000 pregnant women have been vaccinated with no adverse consequences.

MYTH: There are many side effects to these vaccines.

FACT: These vaccines have had no more side effects than most vaccines. They include a day or two of a sore arm, fatigue or malaise, possible fever, and other mild symptoms. These symptoms are not of infection, but of an active immune response, which is a good thing. A few cases of Bell’s palsy (temporary facial paralysis) have been reported. It is unclear if this is related, but it has all been resolved quickly. There are isolated cases of anaphylaxis (severe allergic reaction), possibly related to a preservative/adjuvant called polyethylene glycol (PEG), which is used to make the vaccine more stable and have a better response. PEG is commonly used in toothpaste, shampoo, and bowel preparations. These reactions are rare and easily treated with an EpiPen. There are no known long-term adverse events related to the vaccine. However, there are many reported cases of lingering symptoms (long haulers) from infection with COVID-19, which is a much greater risk than the vaccine.

Relative risk
This virus will likely be with us for our lifetimes. The symptoms of the virus range from none, to mild flu-like symptoms, to hospitalization, and even death. Some symptoms can last from weeks to indefinitely. Eighty percent of all patients who have recovered from COVID-19 have at least one lingering symptom that lasts for weeks or months. The long-term side effects are unknown but are likely very consequential for some. Many viral infections result in post-viral syndromes. For example, herpes simplex can result in lifetime recurring oral and genital lesions. Will COVID-19 lead to any post-viral syndromes? This is not known, but it seems very likely due to the lingering symptoms from acute infection. We may not know for years.

The risk of the vaccination is a sore arm, fatigue, headache, and other mild flu-like symptoms. All reported cases of Bell’s palsy recovered. Anaphylactic reactions are less than five per million doses. There is currently one death from immune thrombocytopenia that is potentially linked to the vaccination. It is an extreme immune response that leads to decreased platelet formation that is usually treatable. Sadly, the 56-year-old victim did not respond to treatment and died of a hemorrhagic stroke. It is unclear what if any role the vaccine had in the development of ITP, but the person’s immune response to the vaccine could have been the trigger.

There are also reports of people dying from a variety of causes within days or weeks of getting the vaccination. With the vaccine being given to more than 35 million people—many of them in their 70s, 80s, and 90s—and an average of 8,000 deaths per day in the US from all causes, of course some people will die in proximity to being vaccinated. This does not mean the vaccine and deaths are linked. We do not know of any long-term potential effects from the vaccines because they are new. But over 130 million doses have been given worldwide since the clinical trials began, and close to a year later we are seeing no problems. Clearly the known risk of infection far outweighs the perceived risks of vaccination.

These vaccines are likely the safest, most tested, and scrutinized vaccines ever developed because multiple pharmaceutical companies are working on them and sharing information. Clinical testing of the vaccines was the same as for all vaccines in the past. There is no risk of the vaccine altering your DNA. There is no risk of it causing COVID-19. It has minimal and typical side effects. It is far more effective than most vaccines (94%-95% effective versus 40%-50% effective for influenza vaccines).

It is estimated that more than 70% of the population must be vaccinated (or infected) to achieve herd immunity and stop the rapid spread of infection. With variants becoming more prevalent, it is essential to increase vaccination quickly to minimize spread. Please get your vaccine and urge your patients and communities to do so as soon as they are eligible!

Dental Equipment From Lions Dental Supply